TODD S. YOUNG - 01 Feb 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: Executive Vice President and Chief Financial Officer
Signature: /s/ Catherine S. Powell, as Attorney-in-Fact for Todd S. Young
Issuer symbol: ELAN
Transactions as of: 01 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Feb 2023, 15:06:58 UTC
Previous filing: 03 Mar 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Conversion of derivative security		+1,562	+31%		6,562	01 Feb 2023	By IRA	F1
holding	ELAN	Common Stock						119,949	01 Feb 2023	Direct
holding	ELAN	Common Stock						2,000	01 Feb 2023	By J. G. Young IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Tangible Equity Units	Conversion of derivative security	$0	-1,562	-100%	$0.000000^*	0	01 Feb 2023	Common Stock	1,562		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Tangible Equity Unit ("TEU") included a prepaid stock purchase contract that automatically settled on February 1, 2023 for 1.5625 shares of the Issuer's common stock.

Remarks:

Executive Vice President and Chief Financial Officer